Acute chest pain (ACP) is one of the most common symptoms encountered in emergency departments. It poses a significant diagnostic challenge due to its diverse etiology, ranging from benign conditions to life-threatening emergencies such as acute coronary syndrome (ACS).
Initial evaluation should include a thorough history and physical examination to identify high-risk features suggestive of ACS. The use of risk stratification tools, such as the HEART score, can aid in decision-making. Electrocardiogram (ECG) and cardiac biomarkers (troponin) are essential in the initial assessment.
Further diagnostic testing depends on the initial risk assessment. Low-risk patients may undergo stress testing or advanced imaging. High-risk patients should be considered for immediate invasive strategies. Coronary computed tomography angiography (CCTA) has emerged as a valuable tool in the evaluation of intermediate-risk patients.
Management strategies are guided by the underlying cause. ACS requires urgent revascularization, either by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Non-cardiac causes of ACP should be managed accordingly, with appropriate referral to specialists when necessary.
Disposition decisions should be individualized, based on the patient's risk profile, diagnostic evaluation, and response to initial management. High-risk patients warrant hospital admission, while selected low-risk patients may be safely discharged with close outpatient follow-up.
ACP represents a complex clinical scenario requiring a systematic approach to ensure appropriate diagnosis and management. Through a combination of clinical assessment, risk stratification, diagnostic testing, and tailored management strategies, healthcare professionals can effectively navigate the challenges posed by this common, yet potentially serious, clinical presentation.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation